SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
of the SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 14, 2014
ATRICURE, INC.
(Exact name of registrant as specified in charter)
| Delaware | 000-51470 | 34-1940305 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 6217 Centre Park Drive West Chester, OH |
45069 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (513) 755-4100
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.07. Submission of Matters to a Vote of Security Holders.
The stockholders of AtriCure, Inc. (the “Company”) voted on four items at the Annual Meeting of Stockholders held on May 14, 2014:
| 1. | The election of nine directors to serve one-year terms expiring at the 2015 Annual Meeting and until their successors have been duly elected and qualified; |
| 2. | A proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2014; |
| 3. | An advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement; and |
| 4. | A proposal to approve the AtriCure, Inc. 2014 Stock Incentive Plan. |
The nominees for director were elected based upon the following votes:
| Director Nominees |
Votes For | Votes Withheld | Broker Non-Votes | |||||||||
| Michael H. Carrel |
18,038,449 | 791,110 | 3,920,552 | |||||||||
| Mark A. Collar |
18,037,900 | 791,659 | 3,920,552 | |||||||||
| Scott W. Drake |
18,066,183 | 763,376 | 3,920,552 | |||||||||
| Michael D. Hooven |
18,038,299 | 791,260 | 3,920,552 | |||||||||
| Richard M. Johnston |
17,313,744 | 1,515,815 | 3,920,552 | |||||||||
| Elizabeth D. Krell, Ph.D. |
18,037,550 | 792,009 | 3,920,552 | |||||||||
| Mark R. Lanning, C.P.A. |
18,037,900 | 791,659 | 3,920,552 | |||||||||
| Karen P. Robards |
17,913,350 | 916,209 | 3,920,552 | |||||||||
| Robert S. White |
18,145,925 | 683,634 | 3,920,552 | |||||||||
The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2014 received the following votes:
| For: |
22,425,798 | |||
| Against: |
321,023 | |||
| Abstain: |
3,290 | |||
| Broker Non-Votes: |
0 |
The advisory vote on the compensation of the Company’s named executive officers as disclosed in the proxy statement received the following votes:
| For: |
17,179,749 | |||
| Against: |
1,605,669 | |||
| Abstain: |
44,141 | |||
| Broker Non-Votes: |
3,920,552 |
The proposal to approve the AtriCure, Inc. 2014 Stock Incentive Plan received the following votes:
| For: |
10,652,711 | |||
| Against: |
8,129,007 | |||
| Abstain: |
47,841 | |||
| Broker Non-Votes: |
3,920,552 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| ATRICURE, INC. | ||||||
| Date: May 15, 2014 | By: | /s/ M. Andrew Wade | ||||
| M. Andrew Wade | ||||||
| Vice President and Chief Financial Officer | ||||||